Saurabh Zanwar @ZanwarSaurabh Twitter profile | Pikagi

Pikagi

Saurabh Zanwar

@ZanwarSaurabh

1,139

Followers

568

Following

66

Media

764

Statuses

Myeloma, Amyloid and Dysproteinemia Fellow @MayoHemeOnc | Former @MAYOMN_IMRES and @TataMemorial | @ManUtd and @bcci | Tweets are my own|

Minnesota, USA

Joined September 2016

Don't wanna be here? Send us removal request.

Pinned Tweet

@ZanwarSaurabh

Saurabh Zanwar

3 months

Out now in @JCO_ASCO ! Our collaborative work: 𝐌𝐨𝐝𝐢𝐟𝐢𝐞𝐝 𝐒𝐭𝐚𝐠𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦 𝐟𝐨𝐫 𝐖𝐚𝐥𝐝𝐞𝐧𝐬𝐭𝐫ö𝐦 𝐦𝐚𝐜𝐫𝐨𝐠𝐥𝐨𝐛𝐮𝐥𝐢𝐧𝐞𝐦𝐢𝐚 (𝐌𝐒𝐒-𝐖𝐌) @MyelomaDrKapoor @myelomaMD @VincentRK @JithmaA @jonaspaludo A brief 🧵 1/

Tweet card media

Simplified Risk Stratification Model for Patients With Waldenström Macroglobulinemia | Journal of...

PURPOSE Patients with Waldenström macroglobulinemia (WM) have disparate outcomes. Newer therapies have emerged since the development of International Prognostic Scoring System, and MYD88L265P...

9

20

74

Last Seen Profiles

@omeraltas57

@sunitavakil

@daylightpiastri

@oknoprime

@Munawar_Trends

@stw46

@Sameh1751996222

@amourhies

@helenraw

@KimRiversa

@AGeorge71577

@LeoMeloSfc

@RivalsFriedman

@the90sstore

@aydinuniemlak

@alnour734469807

@pedalmeapp

@Adrian_UA18

@paulandfionawy1

@RowhaniM88598

@MAZZOT2

@zhangxiaochaoSM

@JES_1972

@nongkeekie

@ka_yh48

@cozwva

@jandakembangstw

@ebnmony

@bookworm368351

@FreeThankElon

@TerenceJ93

@TroySudbrook

@petsandticks

@KhlyRayq

@BullChinaCN

@cleopatraasd

@ZanwarSaurabh

Saurabh Zanwar

2 years

This is a peripheral smear from yesterday’s overnight Hematology call. WBC count of 290K! Can you guess the diagnosis? And a classic clinical phenotype associated with this? @HemOncFellows @MayoHemeOnc

Tweet media one

30

49

241

@ZanwarSaurabh

Saurabh Zanwar

4 years

Matched at Mayo Clinic, Rochester, MN for a hem/onc fellowship! Thankful for an amazing residency program and some phenomenal mentors. Even sweeter to celebrate it with my wife! @MayoMN_IMRES @myelomaMD @MyelomaDrKapoor @AmyOxentenkoMD @CaThompsonMD #MedTwitter #mmsm #lysm

Tweet media one

36

0

223

@ZanwarSaurabh

Saurabh Zanwar

1 year

Delighted to share my academic promotion to Assistant Professor in Medicine and Oncology. Final year of fellowship off to a great start! Thank you @myelomaMD @MyelomaDrKapoor @jonaspaludo for the support and mentorship! Now just need to fit these in the tiny cubicle 😅

Tweet media one

Tweet media two

20

6

120

@ZanwarSaurabh

Saurabh Zanwar

2 years

We have put a man on the moon but somehow we are still not doing a good job at figuring out how to let our patients sleep at night in the hospital! A small concerted effort can go a long way for the well being of our patients.

3

4

100

@ZanwarSaurabh

Saurabh Zanwar

8 months

Incredibly fortunate to be part of the amazing @MayoHemeOnc group, with a very proud tradition of prior hem/onc fellowship recipients of the Mayo Brothers Award! @JithmaA @OncDocBock ! And as always thankful to @MayoCancerCare for funding our research!

@MayoHemeOnc

Mayo Clinic Hematology-Oncology Fellowship

8 months

Congratulations Dr. Zanwar on many recent accomplishments!! Dr. Zanwar was recently awarded the Mayo Brothers Distinguished Fellowship Award in addition to obtaining a Hematology Small Grant and Merit Award. We are amazed by all you do! @ZanwarSaurabh

Tweet media one

10

5

79

14

4

87

@ZanwarSaurabh

Saurabh Zanwar

3 years

Congratulations @JithmaA for receiving the Mayo Brothers Distinguished Fellow Award! Fantastic recognition for an amazing human being and physician! Many more accolades to follow. @MayoHemeOnc

10

5

81

@ZanwarSaurabh

Saurabh Zanwar

3 years

A phenomenal experience draws to a close! Thank you @MayoMN_IMRES and all the amazing mentors who gave me a shot at this! @AmyOxentenkoMD @CaThompsonMD @MyelomaDrKapoor @AMarshallMD @myelomaMD Super excited to start fellowship @MayoHemeOnc !

5

1

74

@ZanwarSaurabh

Saurabh Zanwar

9 months

Almost hitting a deer on the drive to the airport and then walking into the most seamless (read empty) security experience has to be the most Minnesota way to depart for a meeting! #ASH23

Tweet media one

4

0

71

@ZanwarSaurabh

Saurabh Zanwar

3 years

I don’t think I have ever ordered this much potassium in my life than I have in the past 4 weeks on the BMT service! But boy does it feel good when the WBC count goes from 0.1 to 0.2 for the first time!! #smallwins #MedTwitter

3

3

68

@ZanwarSaurabh

Saurabh Zanwar

1 year

Our latest publication looking at outcomes and predictors of development of extramedullary multiple myeloma (EMM): 🧵 @MayoMyeloma @myelomaMD @VincentRK @YiLinMDPhD #MMsm

Tweet media one

6

22

69

@ZanwarSaurabh

Saurabh Zanwar

3 years

Delighted to share that I have been promoted to an academic rank of ‘Instructor in Medicine’ 😬😬 Now that’s an exciting start to fellowship @MayoHemeOnc #medtwitter

6

1

65

@ZanwarSaurabh

Saurabh Zanwar

2 years

I have a love-hate relationship with virtual options for scientific meetings. While it comes with not being able to meet longtime friends and mentors, the snuggles from your 4 month old definitely make up for it. PC: wife who would (rightly) disown me if I travelled #IMS2022

Tweet media one

3

0

68

@ZanwarSaurabh

Saurabh Zanwar

3 years

You know you are working with the A-team when the moonlighter is this impressed!! @SammyPistiolis @MatthewEwyMD @MayoMN_IMRES

Tweet media one

2

3

65

@ZanwarSaurabh

Saurabh Zanwar

9 months

Ever since the kiddo came along, meetings have been bittersweet! Thank you to my brilliant and ever so accommodating wife (who refuses to join this platform) to help me be here and still not far off for lullaby time! #ASH23

Tweet media one

5

2

58

@ZanwarSaurabh

Saurabh Zanwar

2 years

This slide from a lecture today is way to cool to not share!! Also makes me realise that I need to up my coag game in the clinic 😬

Tweet media one

1

13

59

@ZanwarSaurabh

Saurabh Zanwar

3 years

Takeaways from day 1 of career development retreat: 1. Success seen on podiums doesn’t show the past failures 2. Work toward what fills your cup 3. Back yourself 4. A grant getting rejected is a failure only if not resubmitted @MayoHemeOnc @NarjustDumaMD @mpdrc @DavidSteensma

1

6

54

@ZanwarSaurabh

Saurabh Zanwar

3 years

Saw a patient today on one of the most toxic myelosuppresive chemotherapies known to mankind, who runs 6 miles a day and has a hemoglobin of 8.2!! When I proposed cutting back a little, he said he did cut back from 12 mi to 6 mi! The human spirit never ceases to amaze me.

0

0

50

@ZanwarSaurabh

Saurabh Zanwar

1 year

Does lounging count as a developmental milestone for a 14 month old? 🥹🥹

Tweet media one

2

0

52

@ZanwarSaurabh

Saurabh Zanwar

3 years

Delighted to share that our work in Triple Class Refractory Multiple Myeloma was selected for an ASH Abstract Achievement Award! Much more work needed in this rapidly evolving field. ⁦ @MayoMyeloma ⁩ ⁦ @myelomaMD ⁩ ⁦ @MayoHemeOnc ⁩ ⁦⁩

4

0

44

@ZanwarSaurabh

Saurabh Zanwar

2 years

Steps in brewing a cappuccino with a newborn: 1. Grind coffee 2. Change a diaper or two 3. Brew coffee 4. Feed-burp cycle 5. Froth the milk (only take the foam-we like it dry) 6. Hymn her to sleep 7. Drink the already cold but satisfying cappuccino Then restart the 2 hour loop!

1

0

46

@ZanwarSaurabh

Saurabh Zanwar

2 years

This is AML with monocytic differentiation. Classic clinical association is the gum swelling Higher CNS involvement.

2

1

43

@ZanwarSaurabh

Saurabh Zanwar

3 years

So grateful to be part of this amazing program and institution!

@MayoMN_IMRES

Mayo Clinic Internal Medicine Residency Rochester

3 years

7/ The Outstanding Achievement Awards go to Drs. Fadi Adel, David Sanborn, Eli Voth, and Saurabh Zanwar!

Tweet media one

2

1

26

6

0

39

@ZanwarSaurabh

Saurabh Zanwar

1 year

The Bonds forged in the trenches of training at @TataMemorial last long! @rushabh1388

Tweet media one

0

1

41

@ZanwarSaurabh

Saurabh Zanwar

3 years

I finally changed my Starbucks name from the generic ‘Sam’ to my actual name today! After a few trial and errors and some sign language use, my regular caffeine providers now know how to pronounce my name! Feels like I accomplished something 😊

5

0

35

@ZanwarSaurabh

Saurabh Zanwar

3 years

Check out our latest publication discussing the disease heterogeneity, prognostication and personalisation of therapy in multiple myeloma. Thank you @myelomaMD @MayoHemeOnc @MayoMN_IMRES for the opportunity!

4

5

36

@ZanwarSaurabh

Saurabh Zanwar

2 years

AL amyloidosis can be challenging to diagnose. Here we review the clinical presentation, diagnostic testing and prognostication of AL Amyloidosis. 🙏🏼 @MorieGertz and Dr.Muchtar for the mentorship! ⁦ @JNCCN ⁩ ⁦ @MayoAmyloid ⁩ ⁦ @MayoCancerCare ⁩

Tweet card media

Immunoglobulin Light Chain Amyloidosis: Diagnosis and Risk Assessment

Immunoglobulin light chain (AL) amyloidosis is a clonal plasma cell disorder with multiple clinical presentations. The diagnosis of AL amyloidosis requires a high index of suspicion, making a delay...

2

6

36

@ZanwarSaurabh

Saurabh Zanwar

3 years

Our latest publication looking at the rapidly emerging problem of triple class refractory myeloma. Here we describe: ✅Cytogenetic evolution ✅Prognostic markers ✅Outcomes ⁦ @myelomaMD ⁩⁦⁩ ⁦⁦ @MatthewHoMD ⁩ ⁦⁦⁦⁦ @MayoHemeOnc ⁩

Tweet card media

Outcomes of triple class (proteasome inhibitor, IMiDs and monoclonal antibody) refractory patients...

Leukemia - Outcomes of triple class (proteasome inhibitor, IMiDs and monoclonal antibody) refractory patients with multiple myeloma

0

2

32

@ZanwarSaurabh

Saurabh Zanwar

3 years

I will never be able to understand why our patients are not able to know the cost of their care before getting the bill! It is saddening to hear the struggle they have to go through to battle it out with these financial strains on top of fighting such tough diseases.

0

0

31

@ZanwarSaurabh

Saurabh Zanwar

3 years

Came across this paper while looking up a regimen for a patient I am caring for. Such a refreshingly honest conclusion! Please don’t sugarcoat ineffective treatments that don’t benefit the patients. Kudos to the authors!

Tweet media one

0

1

30

@ZanwarSaurabh

Saurabh Zanwar

3 years

Check out our publication describing a cryptic presentation of spontaneous tumor lysis. We also present an algorithm for TLS management. Nice read for internal medicine, Pulm/Crit and Hem/Onc trainees alike. @MatthewHoMD @AjHematology @MayoHemeOnc

Tweet card media

Hiding in (not so) plain sight: Spontaneous tumor Lysis syndrome due to intravascular large B cell...

Click on the article title to read more.

onlinelibrary.wiley.com

2

5

32

@ZanwarSaurabh

Saurabh Zanwar

1 year

Nothing like catching up with lifelong mentors! The ASCO tradition continues @VanitaNoronha @TataMemorial #ASCO2023

Tweet media one

0

2

31

@ZanwarSaurabh

Saurabh Zanwar

4 years

Made breakfast (rare occurrence). Worked out (even rarer). Watched some Champions League football. Played some Coldplay. Read a manuscript and revised another. And yet it’s just 3 pm. Day before the fellowship match is turning out to be a long one! #MedTwitter #NRMP #relativity

2

0

28

@ZanwarSaurabh

Saurabh Zanwar

4 years

This picture from my awesome ID rotation showed up in my reminders today! The first vial of penicillin manufactured in the US!! Who else but the legendary Dr. Walt Wilson to share this piece of history with us!

Tweet media one

0

2

28

@ZanwarSaurabh

Saurabh Zanwar

3 years

If you want to create a horror movie for physicians, just title it ‘Prior Authorization’. ‘Peer to Peer’ a close second place. All the fancy new hem/onc drugs will make it to the credit reels.

1

2

26

@ZanwarSaurabh

Saurabh Zanwar

3 years

Day 2 of Career Development Retreat: 1. Community Oncology: Find your fit. Negotiate work/life balance> $$ 2. Advances need Advocacy 3. No PhD ≠ No lab research 4. Collaboration is key. Get different skill sets together. @IreneGhobrial @GregNowakowski @AlanRosmarinMD @MayoHemeOnc

1

4

28

@ZanwarSaurabh

Saurabh Zanwar

2 years

Our paper looking at BRAF fusions as rare drivers of disease in histiocytic disorders. They are enriched in xanthogranulomas and likely respond to MEK inhibition. ⁦ @JithmaA ⁩ ⁦ @aravindranmd ⁩ ⁦⁦ @BloodCancerJnl ⁩ ⁦⁦ @GauravGoyalMD ⁩

Tweet card media

Clinical and therapeutic implications of BRAF fusions in histiocytic disorders

Blood Cancer Journal - Clinical and therapeutic implications of BRAF fusions in histiocytic disorders

1

8

28

@ZanwarSaurabh

Saurabh Zanwar

2 years

Our recent paper demonstrating immune paresis to be an independent risk factor for severe COVID19 in patients with MGUS. Point prevalence for COVID19 was low at 3% but 1 in 4 had severe COVID-19 ⁦ @MatthewHoMD ⁩ ⁦ @myelomaMD ⁩ ⁦ @VincentRK ⁩

Tweet card media

Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undeterm...

Two Letters to Blood address the risks of COVID-19 in populations with precursors of hematological disease. In the first article, Miller and colleagues rep

ashpublications.org

0

6

27

@ZanwarSaurabh

Saurabh Zanwar

3 years

Why do I love my fellowship: @rleonferre gave an amazing 1:1 education session on triple negative breast cancer over zoom…during a time he was supposed to be away! @MayoHemeOnc

1

3

25

@ZanwarSaurabh

Saurabh Zanwar

3 years

Laughing and crying at the same time! So true @IDdocAdi

@IDdocAdi

Adi

3 years

“I will not take on new projects I have no time for” . . Sees new project:

9

64

506

0

3

26

@ZanwarSaurabh

Saurabh Zanwar

9 months

If you are at the poster session tonight at #ASH23 , come find us at Poster 3030 as we discuss our data on prognostication in Waldenstrom Macroglobulinemia. And kudos @ASH_hematology for printing and hanging the poster!! Such a nice initiative!

Tweet media one

1

3

25

@ZanwarSaurabh

Saurabh Zanwar

3 years

How cool is it when your friends and colleagues’ work gets mentioned during the morning didactics! Last week was @arjunlakshmanMD ’s work in myeloma and this week was @StevenHwangMD ’s work in HIT! Looking forward to the next three years of awesomeness! @MayoHemeOnc

0

0

25

@ZanwarSaurabh

Saurabh Zanwar

2 years

Waldenstrom Macroglobulinemia is an intriguing disease with an increasingly personalised therapy. We cover the latest in WM in this review. ⁦ @JithmaA ⁩ ⁦ @MayoCancerCare ⁩ ⁦ @MayoHemeOnc ⁩

Tweet card media

Treatment paradigm in Waldenström macroglobulinemia: frontline therapy and beyond - Saurabh Zanwar,...

Waldenström macroglobulinemia (WM) is an indolent lymphoplasmacytic lymphoma. Recent strides made in the genomic profiling of patients with WM have led to the i...

journals.sagepub.com

3

6

21

@ZanwarSaurabh

Saurabh Zanwar

4 years

A nice morning run on the trail right behind home! #rochestermn #fallcolors

Tweet media one

1

0

21

@ZanwarSaurabh

Saurabh Zanwar

3 years

Do you get paranoid if you don’t get any pages on a home call? Test paged myself, bugged my colleague @JithmaA to make sure I pulled the right pager. Doesn’t help if you demonstrate such behaviours when your wife is a psychiatrist. #MedTwitter

3

0

21

@ZanwarSaurabh

Saurabh Zanwar

4 years

Check out our latest ASCO Daily News commentary: Frontline Treatment of Symptomatic MYD88 L265P Mutant Waldenstrom Macroglobulinemia #ASCODailyNews @ASCO @MyelomaDrKapoor @JithmaA @MayoMyeloma @MayoMN_IMRES

Tweet card media

Frontline Treatment of Symptomatic MYD88L265P-Mutant Waldenstrom Macroglobulinemia

The discovery of the highly recurrent, gain-of-function MYD88L265P mutation, harbored by more than 90% of patients with Waldenstrom macroglobulinemia (WM), was critical in deepening our understanding...

dailynews.ascopubs.org

1

2

20

@ZanwarSaurabh

Saurabh Zanwar

2 years

Another riveting twitter spaces discussion by leaders in the field on immune therapies in MM and Covid-19 @VincentRK @NoopurRajeMD @szusmani . Contd use Evusheld, additional boosters seemingly the key. Curious to see the duration of protection from additional boosters. #IMS2022

2

2

21

@ZanwarSaurabh

Saurabh Zanwar

1 year

And that’s a wrap to a fulfilling week. So many inspiring stories and amazing science. Such detailed feedback on grant proposals! Didn’t ever imagine we would labs (wet and dry) in a hotel! Thank you @AACR @rosslevinemd @christine_lovly for the wonderful opportunity 🙏🏼 #AACRMBCO

Tweet media one

0

2

21

@ZanwarSaurabh

Saurabh Zanwar

9 months

Hey @MatthewHoMD you may have missed #ASH23 , but your papers are doing the rounds! @TheBianchiLab

Tweet media one

2

0

21

@ZanwarSaurabh

Saurabh Zanwar

3 years

So true. My Mom just recovered from COVID-19 last month and now Dad got diagnosed and admitted. It is really difficult to not be able to travel but thankful they are able to get good care. Cannot imagine what people without support systems are going through.

@VincentRK

Vincent Rajkumar

3 years

As COVID rips through India, the nearly 100,000 doctors of Indian origin who are in the US feel both helpless & determined to help at the same time. Most of us have close family in India. Every few hours we get calls about some friend or relative who's very ill with COVID.

37

171

1K

6

2

21

@ZanwarSaurabh

Saurabh Zanwar

3 years

Wellness during busy inpatient services doesn’t have to be something extravagant. A fascinating conversation about academia over a nice cup of @cafesteamMN with the amazing @AMansfieldMD goes a long way! @MayoHemeOnc @MayoMN_IMRES #MedTwitter

1

1

19

@ZanwarSaurabh

Saurabh Zanwar

1 year

Six years is too long of time to meet @AnantRamaswamy ! The best senior we could have hoped for in training ! So glad to see all your amazing work in improving the care for patients with hepatobiliary malignancies. @TataMemorial

Tweet media one

2

0

20

@ZanwarSaurabh

Saurabh Zanwar

2 years

What doesn’t kill you makes you stronger. Except writing a grant. It just tortures. @JithmaA @arjunlakshmanMD I owe you guys one.

2

1

20

@ZanwarSaurabh

Saurabh Zanwar

1 year

Come check out our posters in Hall A this morning at #ASCO23 : Board #14 : Extramedullary myeloma (EMM) treatment outcomes, including with CAR-T and bispecifics Board #35 : Predictors for development of EMM and it’s prognostic impact. @MayoHemeOnc @MayoCancerCare @MayoMyeloma #mmsm

0

2

18

@ZanwarSaurabh

Saurabh Zanwar

2 years

Best World Cup final ever!!!

2

0

19

@ZanwarSaurabh

Saurabh Zanwar

1 year

Absolutely love this! To be able to do collaborative research in such busy clinical practices is a feat to be lauded! So great to see so many friends and colleagues in one picture!

@oncologician

Nirmal Raut

1 year

Oral triple metronomic therapy was statistically significant to treatment of physician choice - Kudos !!! @TweetRushabh #ASCO23 @DrVijayPatil11 @BharatBhos77102 @SuyogCancer

Tweet media one

Tweet media two

Tweet media three

Tweet media four

3

14

39

1

2

19

@ZanwarSaurabh

Saurabh Zanwar

9 months

So true. Attended my First ASH meeting in 2015 when I was a trainee in India! @TataMemorial provided a generous grant but the overhead was still about two months of rent in Mumbai 😅 Honestly it was the jet lag that I couldn’t live with. Yawned my way through the whole meeting!

@nihardesai7

𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM

9 months

A lot of awesome hematologists from a lot of LMIC cannot afford to go to #ASH23 or any major conference for that matter 😭 It's not just the registration cost, but also the travel and stay that's prohibitively expensive 😭 Attending it virtually is a great idea ! #MedTwitter

8

11

95

1

3

17

@ZanwarSaurabh

Saurabh Zanwar

1 year

CNS involvement by lymphoplasmacytic lymphoma, aka Bing Neel Syndrome, is a rare complication. We describe our experience in this publication and suggest an algorithm for diagnosis and Rx 🧵 @MayoMyeloma @MyelomaDrKapoor @JithmaA Free link:

1

4

18

@ZanwarSaurabh

Saurabh Zanwar

2 years

What counts as high risk MM? -t(4;14) is heterogenous with impact determined by breakpoint location -Del17p allelic burden (10/20/55) still debated -No t(14;16) in R2-ISS All this while many centres without access to PC enriched FISH! Thoughts? @bdermanmd @AjayNookaMD #IMS2022

3

5

18

@ZanwarSaurabh

Saurabh Zanwar

1 year

If one doesn’t already exist, we need a ‘Thank your Pathologist’ day! So fortunate to be able to regularly chew the brains of our amazing Pathologists! @MayoHemeOnc @MayoClinicPath

1

1

18

@ZanwarSaurabh

Saurabh Zanwar

2 years

Excellent discussion at #IMS2022 on incorporating frailty assessment in determining optimal treatment. Frailty indices are prognostic but are they practically applicable in busy clinics? As @MorieGertz puts it “Science vs Practice”. ‘Eyeball’ test still the prevalent practice

4

2

18

@ZanwarSaurabh

Saurabh Zanwar

3 years

Check out our paper looking at treatment options post lenalidomide maintenance and impact of duration of maintenance on outcomes in myeloma ⁦ @myelomaMD ⁩ ⁦⁦ @VincentRK ⁩⁦ @MatthewHoMD ⁩ ⁦⁦ @BloodCancerJnl ⁩ ⁦ @MayoHemeOnc ⁩ #mmsm

Tweet card media

The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in...

Blood Cancer Journal - The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM)

0

4

18

@ZanwarSaurabh

Saurabh Zanwar

3 years

Check out our recent paper in British Journal of Haematology looking at predictors of disease progression and outcomes of Smoldering/Asymptomatic Waldenstrom Macroglobulienmia @JithmaA @MyelomaDrKapoor @myelomaMD @MayoLymphoma

0

2

16

@ZanwarSaurabh

Saurabh Zanwar

9 months

I have started and finished 3 different medical training programs since the last time United won at Anfield in the league! And if we lose this Sunday, it will likely be four. Thank you for the scars @ManUtd ! #MUFC #LIVMUN

3

1

17

@ZanwarSaurabh

Saurabh Zanwar

2 years

Same day same journal Me: This case report is never getting accepted. Why am I doing this!? Journal: favourable review Also me: This other paper has really interesting data. Will definitely get in. Journal: Nah. Reject without revisions. Moral: don’t presume #MedTwitter

0

0

16

@ZanwarSaurabh

Saurabh Zanwar

3 years

Me: Your lung cancer is progressing and second line Rx is docetaxel. Response rate of 10-15% with substantial toxicities. Patient: I’ll take it (no questions asked) Me: you should consider getting the Covid19 shot. It is highly efficacious and safe. Patient: Nope. 🤷🏽

0

1

16

@ZanwarSaurabh

Saurabh Zanwar

4 years

Our recent review on immune based therapies in myeloma! The future of cellular therapies in myeloma is bright and busy!

@VincentRK

Vincent Rajkumar

4 years

7. Review of immunotherapy for myeloma.

1

3

10

1

1

13

@ZanwarSaurabh

Saurabh Zanwar

2 years

Excellent session on disease monitoring in myeloma at #IMS22 hosted by @VincentRK @myelomaMD @szusmani How big of a microscope do we need for MRD(10^5 vs10^6)? Best imaging technique? When to act for an expanding subclone? Lots of intriguing questions needing prospective study

1

0

16

@ZanwarSaurabh

Saurabh Zanwar

4 years

Very elderly (≥75 years) patients with Waldenstrom Macroglobulinemia continue to do worse compared to the age, sex and calendar-year matched general US population. Higher prevalence of poor prognostic markers also noted in the very elderly. @JithmaA

1

1

16

@ZanwarSaurabh

Saurabh Zanwar

3 years

Motivation to continue masking up

Tweet media one

0

0

16

@ZanwarSaurabh

Saurabh Zanwar

9 months

It’s ASH time of the year! Look forward to some exciting science and seek some inspiration. Excited to present our data on the impact of pre-ASCT immune composition and risk of tMN and MM outcomes (thanks @Taxkourel @MayoMyeloma ) #ASH23 🧵

Tweet media one

1

2

16

@ZanwarSaurabh

Saurabh Zanwar

3 years

Chalk talk time! Medicine morning reports are always fun. We discussed tumor lysis syndrome yesterday. And yes, I have the handwriting of a 3 year old! #MedTwitter

Tweet media one

0

0

15

@ZanwarSaurabh

Saurabh Zanwar

9 months

Just the most amazing, pragmatic and bite sized recommendations for active MM. Perfect resource for trainees looking to assimilate the ever expanding data #mmsm @HemOncFellows @MayoHemeOnc @TheFellowOnCall

@VincentRK

Vincent Rajkumar

9 months

Updated treatment approach to newly diagnosed myeloma based on new #ASH23 data. Explanation for changes in thread. #MedTwitter 1/

Tweet media one

14

167

423

0

3

15

@ZanwarSaurabh

Saurabh Zanwar

9 months

Excellent talk yesterday by the amazing @ADispenzieri and @awechalekar on the heels of #ASH23 on diagnosis and management of AL Amyloidosis! So much good info on supportive care as well!

Tweet media one

0

3

14

@ZanwarSaurabh

Saurabh Zanwar

3 years

Why is it so hard to unsubscribe from paper journals🤷🏽 Unsubscribed the print version through my account. Didn’t work. Emailed customer support. Didn’t work. Ended up moving during this and didn’t update my address with the journal. Still get them faithfully! #MedTwitter

1

0

13

@ZanwarSaurabh

Saurabh Zanwar

3 years

Do you have a test that you always order and it never provides you the answer for what’s going on with your patient?🤔 For me it has to be TSH. #MedTwitter

3

1

14

@ZanwarSaurabh

Saurabh Zanwar

3 years

@AaronGoodman33 Haha. Classic Dr. House scenarios. Clarkson Syndrome. The eyes don’t see what the mind doesn’t know. We reported one such clinical scenario

Tweet card media

66-Year-Old Man With Recurrent Hypotension and Flank Pain - PubMed

66-Year-Old Man With Recurrent Hypotension and Flank Pain

pubmed.ncbi.nlm.nih.gov

0

1

13

@ZanwarSaurabh

Saurabh Zanwar

4 years

Our collaborative paper looking at a prognostic index predicting survival in transformed Waldenström macroglobulinemia. Out now in @Haematologica @MyelomaDrKapoor @JithmaA @MayoMN_IMRES

Tweet card media

A prognostic index predicting survival in transformed Waldenström macroglobulinemia - PubMed

Histological transformation into diffuse large B-cell lymphoma is a rare complication in patients with Waldenström macroglobulinemia (WM) usually associated with a poor prognosis. The objective of...

pubmed.ncbi.nlm.nih.gov

2

0

12

@ZanwarSaurabh

Saurabh Zanwar

3 years

Never have I ever seen such medically complex patients before my preanesthetic medical evaluation clinic rotation! 😥 And I have cared for patients undergoing allogenic transplants before! @davidharmonMD @GColbensonMD @TheEKGGuy #medtwitter

1

0

13

@ZanwarSaurabh

Saurabh Zanwar

3 years

So we had to get 6 PET-CTs in the last 4 weeks on an inpatient Medicine service! And yes, all were indicted. Needless to say, it has been an absolutely fascinating month of diagnostic medicine! #MedTwitter

1

0

11

@ZanwarSaurabh

Saurabh Zanwar

4 years

Evidence based cardiology ✅ Patient centered medicine ✅ Reminiscing the life and career of Diego Maradona post rounds✅ That’s a wrap on another wonderful week on the Cardiology floors with the one and only Dr. Brenes Salazar! @CardioGeriatric @SammyPistiolis @TheEKGGuy

0

0

11

@ZanwarSaurabh

Saurabh Zanwar

1 year

Excellent talk by @SurbhiSidanaMD @AmandaNizamMD @JoshuaReuss and @HaradaGuilherme for fellows transitioning to early career faculty! Excellent insight and candid tips and tricks! #ASCO23

Tweet media one

0

1

12

@ZanwarSaurabh

Saurabh Zanwar

3 years

The dream team! So excited for you guys!

@DavidSanbornMD

David Sanborn, M.D.

@DavidSanbornMD

3 years

There are some new sheriffs in town @MayoMN_IMRES ! @GColbensonMD @EmilyOlsonMD @EliVothMD @CaThompsonMD #Chiefs #DayOne

Tweet media one

3

9

129

0

0

12

@ZanwarSaurabh

Saurabh Zanwar

1 year

Absolute gold for @HemOncFellows ! Such a nice, practical collation. #bookmark

@VincentRK

Vincent Rajkumar

1 year

Myeloma drugs — Dosing and schedule What I do in practice #MedTwitter 1. Dex: 40 mg once a week age <70; 20 mg if age >70 or frail Stop Dex at around one year if good response. Days 1-4, 8, 15, 22 schedule for 1st cycle only in cast nephropathy; or VDT-PACE type regimen

23

203

689

1

2

10

@ZanwarSaurabh

Saurabh Zanwar

2 years

@nihardesai7 @AdiG1993 @ArijitBishnu @Prasshmehta @BijoyTelivala @Doxotaxel @NicoGagelmann It’s a shame that Hemepath folks even have to consider this. Largely happens because of the difference in remuneration. Hope we can address that. Hempath is a super difficult to begin with(tougher than clinical hem in some situations). And by switching we lose all that expertise.

0

1

12

@ZanwarSaurabh

Saurabh Zanwar

1 year

Such a pleasure to chat with the one and only @marklewismd !! Few more grey hair compared to the portrait hanging in the @MayoHemeOnc graduates but all the wisdom that comes with it 😉 #ASCO23

Tweet media one

2

1

12

@ZanwarSaurabh

Saurabh Zanwar

3 years

Check out our recent publication: Bendamustine-Rituximab demonstrates superior outcomes (ORR,PFS) among frontline non-BTK therapy options for Waldenstrom Macroglobulinemia irrespective of MYD88 status.

0

0

12

@ZanwarSaurabh

Saurabh Zanwar

10 months

Couldn’t think of a better person for this than @cspramesh ! True visionary. Have learnt so much from you about clinical trial designs and complex tumor boards back in the day! @TataMemorial @VanitaNoronha @sujithonco @CancerGridIndia

@cspramesh

Pramesh CS

10 months

@ASCO Elections-stellar candidates out there. I'm honored to be nominated for the Board of Directors (International Member). I hope to serve ASCO in this role to promote access to affordable high-quality cancer care-everywhere has more about the candidates

15

34

105

0

2

11

@ZanwarSaurabh

Saurabh Zanwar

1 year

Every now and then, I come across an amazing fact about @MayoClinic . First CT imaging performed in North America!

Tweet media one

0

3

11

@ZanwarSaurabh

Saurabh Zanwar

3 years

Congratulations Dr. Dro!! Best of luck! @E_D_Bezerra

@OSUHematology

OSU Hematology

3 years

Excited to announce that @E_D_Bezerra will be joining the @OSUCCC_James team this summer from the Mayo Clinic in our #BMT and #CellularTherapy program. We're thrilled to bring his expertise and clinical care to @osuwexmed @Pelotonia

Tweet media one

4

5

39

1

0

11

@ZanwarSaurabh

Saurabh Zanwar

3 years

Everyone needs a little bit of that Minnesota Sun when it’s 70F outside!! #MN

Tweet media one

1

0

11

@ZanwarSaurabh

Saurabh Zanwar

2 years

@JaedaRothMD @MayoMN_IMRES @jamchugh @MelissaBoginMD @CaThompsonMD Congratulations and best of luck! You guys are going to rock! Whoever is the Food Czar: heavy lies the crown 😬

1

0

10

@ZanwarSaurabh

Saurabh Zanwar

4 years

Phenomenal thread! Goes to show the effort that goes into the studies that we criticise (read eviscerate) in our journal clubs. Provides some context into some of the less explainable inclusions/exclusions in the protocols. Next time, please go a little gentle on the authors! 😊

@VincentRK

Vincent Rajkumar

5 years

So, you want to lead a randomized trial? I ran a poll: How many people have near veto power over the approval & design of an investigator initiated oncology randomized trial? Only 23% guessed right. Answer: >50! @RielyMD @mtmdphd Here are the steps to do an RCT? Thread 1/

4

83

190

0

2

9

@ZanwarSaurabh

Saurabh Zanwar

2 years

@MatthewHoMD @KirtanPatolia @ASanchez_PS Good ones @MatthewHoMD I ll start with an onc bias: Necrolytic migratory erythema: glucagonoma Eyes have so many of these. Not always 100% but close: KF Rings-Wilson disease Lisch nodules: NF1 Dislocated lens: Marfan (up and out) homocystinuria (down and in).

1

0

9

@ZanwarSaurabh

Saurabh Zanwar

9 months

Had a visitor bright and early this morning! #ASH23

Tweet media one

0

1

10

@ZanwarSaurabh

Saurabh Zanwar

3 years

Proud to be a graduate of this place! Historic day indeed

@ACTREC_TMC

ACTREC-TMC

3 years

First CAR-T therapy in India in @ACTREC_TMC Friday, 4th June, 2021. Culmination of years hard work of @DrGauravNarula @TataMemorial @purwarrahul2 @iitbombay ! Red-letter day, history of Indian oncology. Pray for complete cure of patient @ISMPOofficial @cspramesh @pankajch37

54

104

382

0

0

10

@ZanwarSaurabh

Saurabh Zanwar

1 year

Tec + Tal with an 85% ORR in R/R extramedullary myeloma! Needs longer FU and safety data but dual bispecific combination seems feasible and exciting! Check out our experience in Extramedullary myeloma and Immune effector therapies: #ASCO23 #mmsm

Tweet media one

0

1

10

@ZanwarSaurabh

Saurabh Zanwar

1 year

Am I the only one who thinks this Liverpool kit looks like a heatmap??

Tweet media one

3

1

10

@ZanwarSaurabh

Saurabh Zanwar

2 years

@nihardesai7 In short, With a lot of difficulty 😬 The exams and repeating training is the easy part. Tougher part is to get interviews for residency because you are ‘older’. Kept hearing phrases “YOG is ancient”, “retraining never works” etc. Highly recommended if truly passionate.

2

0

9

@ZanwarSaurabh

Saurabh Zanwar

11 months

Diving straight from the 1 month Hematology Consult service rotation into #IMS23 week! Virtual immersion again this year and @RahulBanerjeeMD ’s posts are as close to the in person experience I’ll get. Exclusively Greek food takeout this week in spirit of the meeting😁

1

1

9

@ZanwarSaurabh

Saurabh Zanwar

4 years

I guess you can call this one Weather Art! #minnesota

Tweet media one

1

0

8